Track topics on Twitter Track topics that are important to you
Japan’s Daiichi Sankyo has joined an open innovation research initiative that will try to develop a therapy for type 1 diabetes based on insulin-producing cells. The drugmaker has teamed up with Tokyo Institute of Technology for the project, which...
Original Article: Daiichi Sankyo takes option on diabetes stem cell start-upNEXT ARTICLE
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...